Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 KRANKHEITSBILD NETZWERK REGISTRY PROJEKTE ANMELDEN
 
 
  
Aktuelles vom Europäischen HK Netzwerk -
--->Aktuelles
[-]Das Projekt
--->Sponsor
--->[+]Vorstand
--->[+]Writing Committee Strategic ...
--->[+]Wissenschaftl. Begutachtung
--->Zentrale Koordination
--->Länderkoordination
--->Fellowship Programme
--->[+]Constitution
--->[+]Voting/Nomination
--->[-]Mitglieder
--->Antrag
[-]Standorte
--->[+]Österreich
--->[+]Belgien
--->[+]Tschechische Republik
--->[-]Dänemark
--->[+]Coordination
--->HD Associations
--->Aarhus
--->Copenhagen
--->Odense
--->[+]Finnland
--->[+]Frankreich
--->[-]Deutschland
--->Koordination
--->Selbsthilfe
--->Standard of Care
--->Aachen
--->Berlin
--->Bochum
--->Bonn
--->Dresden
--->Dinslaken
--->Düsseldorf
--->Erlangen
--->Freiburg
--->Hamburg
--->Hannover
--->HH-Heiligenhafen
--->Itzehoe
--->Kassel
--->[+]Lübeck
--->Marburg-KPP
--->Mainz
--->München
--->München-LMU
--->Münster
--->Rostock
--->Kontakte
--->Taufkirchen
--->Ulm
--->[+]Würzburg
--->[+]Ireland
--->[-]Italien
--->Koordination
--->Selbsthilfe
--->Bari
--->Bologna
--->Brescia
--->Cagliari
--->Florenz
--->Genua
--->Mailand
--->Neapel
--->Pisa
--->Pozzilli
--->Rom
--->Rm-Mi-Fi LIRH
--->Rome-Sant'Andrea
--->[-]Niederlande
--->Coordination
--->HD Associations
--->Enschede
--->Groningen
--->Leiden
--->[+]Maastricht
--->Nijmegen
--->[+]Norwegen
--->[+]Polen
--->[-]Portugal
--->Coordination
--->Coimbra
--->Lisbon - Central
--->Lisbon - Fernando-Fonseca...
--->Lisbon - Santa Maria
--->Porto - São João
--->Vila Real
--->[+]Russia
--->[+]Spanien
--->[+]Schweden
--->[+]Schweiz
--->[-]U.K.
--->Koordination
--->Selbsthilfe
--->Links
--->[+]UKHDN
--->Standard of Care
--->Aberdeen
--->[+]Ayr
--->Belfast
--->Birmingham
--->[+]Blandford Forum
--->Bristol
--->Cambridge
--->Cardiff
--->Dundee
--->Edinburgh
--->Exeter
--->Fife
--->Forth Valley
--->Glasgow
--->Gloucester
--->Hull
--->Inverness
--->Launceston
--->Leeds
--->Leicester
--->Liverpool
--->London - Guy's Hospital
--->London - Hammersmith
--->London - NHNN
--->London - Royal Hospital
--->London St. George´s
--->Manchester
--->Newcastle-Upon-Tyne
--->[+]Northampton
--->Nottingham
--->Oxford
--->[+]Plymouth
--->Poole
--->Preston
--->Reading
--->[+]Sheffield
--->Southampton
--->Stoke-on-Trent
--->Swindon
--->Wrexham
--->[+]Outside Europe
[+]Arbeitsgruppen
[-]Veranstaltungen
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[+]EHDN 2012
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[-]Kommunikation
--->Kontakt
--->Chat
--->Mailinglisten - Öffentlich
--->Newsletter
--->Stellenangebote
Pridopidine Dose Escalation Trial endorsed by EHDN.

At the meeting of the EC of EHDN on July 9, 2013 a Phase II dose escalation trial of pridopidine as proposed by Teva Pharmaceuticals was endorsed. Endorsement by the EC was preceded by a joint review of the HSG Scientific Review Committee and the Scientific and Bioethical Advisory Committee (SBAC) of EHDN.[back]
impressum | datenschutz | haftungsausschluss | nutzungsbedingungen